Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
TestGrid Introduces CoTester™, World's First AI Software Tester!
-
TransPerfect’s GlobalLink CCMS Helps ISACA Build a Next-Generation Learning & Research Platform
-
TESSAN's WTA Series: Redefining Travel Charging with the Ultimate Award-Winning Travel Adapter
-
Aire Networks Deploys Infinera’s ICE-X Intelligent Coherent Pluggable Solution to Increase Capacity of Its Single-fiber Network
-
Sono-Tek Announces Preliminary Net Sales for Q4 and FY2024 and Provides Preliminary Sales Guidance for Q1 FY2025 and FY2025
-
Syncromune® Inc. Presents Positive Results from SYNC-T™ SV-102 Phase 1 Trial at AACR Annual Meeting 2024
-
ORYZON Announces U.S. FDA Clearance of CTEP-CRADA Phase I/II Clinical Trial Sponsored by NCI for Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
-
Treatment.com AI welcomes the Federal Government's announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption
-
First Federal Savings Bank and ICBA Share Money Management Tips to Help Americans Be More Financially Resilient
-
ManTech Names Barbara Haines-Parmele as Executive Vice President and General Manager of Intelligence Sector
-
Veriato Launches Next Generation Insider Risk Management Solution to Meet Today’s Organizational Cybersecurity Needs
-
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
-
Auddia Announces Issuance of Core AI Patent
-
TESSAN's WTA Series: Redefining Travel Charging with the Ultimate Award-Winning Travel Adapter
-
LOBO EV Receives Commitment for Support from Local Government
-
GDC Unveils Its Next Leap into the Fusion of Art and AI-Generated Video Technology with a Captivating Short Film "Forgotten Planet"
-
TestGrid Introduces CoTester™, World's First AI Software Tester!
-
Treatment.com AI welcomes the Federal Government's announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption
-
Osisko Announces Q1 2024 Geo Deliveries and Select Asset Updates
-
ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
-
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
-
TeraWulf Announces Continued Industry-Leading Cash Production and $30 Million Debt Repayment
-
Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting
-
Metagenomi to Present at Upcoming Scientific Meetings
-
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
-
Recently Updated and Extended Joint Development Agreement between ExxonMobil Technology and Engineering Company and FuelCell Energy Aimed at Accelerating Access to Carbonate Fuel Cell Technology for C
-
Medeloop Achieves Milestone with One Million Patient Health Records, Pioneering Advances in Clinical and Translational Research
-
Dalrada Financial Corporation Subsidiary, Dalrada Home Corp., forms Advisory Board and Announces Inaugural Members
-
MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
-
Rush Street Interactive Appoints Brian Sapp as Chief Marketing Officer
-
Foremost Lithium Confirms 25.92 Metres of Lithium Mineralization Including 1.09% Li2O Across 10 Metres at its Zoro Property, Manitoba Canada
-
New Research From Inovalon and Harvard Analyzes Medicare Advantage Plan Design Impact on Healthcare Utilization and Health Equity
-
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Associati
-
Perspective Therapeutics to Participate at Upcoming April Investor Conferences
-
Freshworks to Announce First Quarter 2024 Financial Results on May 1, 2024
-
Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
-
Watches World Introduces Pre-owned Luxury Bags, Capitalizing on Market Trends and Sustainable Luxury
-
D-BOX Technologies’ Haptic Experience Coming to More than 50 Additional Cinemark Auditoriums by Year-End 2024
-
CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors
-
Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology
-
Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer
-
INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024
-
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
-
AACSB Announces 2024 Class of Influential Leaders
-
Quantexa Recognized in Chartis’s Inaugural Financial Crime and Compliance 50 Rankings as Top Ranked Solution Provider
-
Michelin: 2023 UNIVERSAL REGISTRATION DOCUMENT
-
Digital Ally Announces Multi-Year Agreement with the Kansas City Chiefs
-
Kalmar hybrid straddle carriers to help Med Europe Terminal improve environmental performance
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
ASML reports transactions under its current share buyback program
